| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |